Evidence map›Paper›PMID 34300727›Full record

ArticleMaterials (Basel, Switzerland)2021

The Physico-Chemical Properties and Exploratory Real-Time Cell Analysis of Hydroxyapatite Nanopowders Substituted with Ce, Mg, Sr, and Zn (0.5-5 at.%).

Iuliana Maria Chirică, Ana-Maria Enciu, Teddy Tite, Maria Dudău, Lucian Albulescu, Simona Liliana Iconaru, Daniela Predoi, Iuliana Pasuk, Monica Enculescu, Cristian Radu and 6 more

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Iuliana Maria ChiricăNational Institute of Materials Physics, RO-077125 Măgurele, Romania.ORCID 0000-0003-4698-9857
Ana-Maria Enciu"Victor Babes" National Institute of Pathology, RO-050096 Bucharest, Romania.ORCID 0000-0002-8122-1096
Teddy TiteNational Institute of Materials Physics, RO-077125 Măgurele, Romania.
Maria Dudău"Victor Babes" National Institute of Pathology, RO-050096 Bucharest, Romania.
Lucian Albulescu"Victor Babes" National Institute of Pathology, RO-050096 Bucharest, Romania.
Simona Liliana IconaruNational Institute of Materials Physics, RO-077125 Măgurele, Romania.ORCID 0000-0002-9139-5903
Daniela PredoiNational Institute of Materials Physics, RO-077125 Măgurele, Romania.
Iuliana PasukNational Institute of Materials Physics, RO-077125 Măgurele, Romania.
Monica EnculescuNational Institute of Materials Physics, RO-077125 Măgurele, Romania.
Cristian RaduNational Institute of Materials Physics, RO-077125 Măgurele, Romania.
Cătălina Gabriela MihalceaNational Institute of Materials Physics, RO-077125 Măgurele, Romania.
Adrian-Claudiu PopaNational Institute of Materials Physics, RO-077125 Măgurele, Romania.
Nicoleta RusuNational Institute for Chemical Pharmaceutical Research and Development, RO-031299 Bucharest, Romania.
Sultana NiţăNational Institute for Chemical Pharmaceutical Research and Development, RO-031299 Bucharest, Romania.
Cristiana Tănase"Victor Babes" National Institute of Pathology, RO-050096 Bucharest, Romania.
George E StanNational Institute of Materials Physics, RO-077125 Măgurele, Romania.ORCID 0000-0003-0289-8988

Funding

Ministerul Cercetării şi Inovării Core Program 21NUnitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii PN-III-P1-1.1-TE-2019-0463Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii PN-III-P1-1.2-PCCDI-2017-0062
6 · The paper itself

Abstract

Cation-substituted hydroxyapatite (HA), standalone or as a composite (blended with polymers or metals), is currently regarded as a noteworthy candidate material for bone repair/regeneration either in the form of powders, porous scaffolds or coatings for endo-osseous dental and orthopaedic implants. As a response to the numerous contradictions reported in literature, this work presents, in one study, the physico-chemical properties and the cytocompatibility response of single cation-doped (Ce, Mg, Sr or Zn) HA nanopowders in a wide concentration range (0.5-5 at.%). The modification of composition, morphology, and structure was multiparametrically monitored via energy dispersive X-ray, X-ray photoelectron, Fourier-transform infrared and micro-Raman spectroscopy methods, as well as by transmission electron microscopy and X-ray diffraction. From a compositional point of view, Ce and Sr were well-incorporated in HA, while slight and pronounced deviations were observed for Mg and Zn, respectively. The change of the lattice parameters, crystallite size, and substituting cation occupation factors either in the Ca(I) or Ca(II) sites were further determined. Sr produced the most important HA structural changes. The in vitro biological performance was evaluated by the (i) determination of leached therapeutic cations (by inductively coupled plasma mass spectrometry) and (ii) assessment of cell behaviour by both conventional assays (e.g., proliferation-3-(4,5-dimethyl thiazol-2-yl) 5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium assay; cytotoxicity-lactate dehydrogenase release assay) and, for the first time, real-time cell analysis (RTCA). Three cell lines were employed: fibroblast, osteoblast, and endothelial. When monophasic, the substituted HA supported the cells' viability and proliferation without signs of toxicity. The RTCA results indicate the excellent adherence of cells. The study strived to offer a perspective on the behaviour of Ce-, Mg-, Sr-, or Zn-substituted HAs and to deliver a well-encompassing viewpoint on their effects. This can be highly important for the future development of such bioceramics, paving the road toward the identification of candidates with highly promising therapeutic effects.

Indexed as

biocompatibilitybio-functionalitycompositionICP-MSreal-time cell analysisstructuresubstituted hydroxyapatite

Identifiers

PMID34300727
PMCPMC8305395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.